Source link : https://www.newshealth.biz/health-news/glp-1-agonists-for-diabetes-tied-to-lower-hyperkalemia-rates/
Hyperkalemia in type 2 diabetes occurred less often with GLP-1 receptor agonists in routine care than dipeptidyl peptidase-4 (DPP-4) inhibitors, a large observational study in Sweden showed. Over a median 3.9-month treatment time, GLP-1 agonists were linked with a 39% reduced risk for hyperkalemia — a potassium level greater than 5.0 mEq/L — compared with […]
Author : News Health
Publish date : 2024-08-12 21:40:53
Copyright for syndicated content belongs to the linked Source.
Categories